New antibiotic under watch for High-Risk patients
NCT ID NCT06864585
Summary
This study aims to monitor the safety and real-world effectiveness of the antibiotic Zavicefta in Japan. It will include about 59 patients who have severe bloodstream infections (sepsis) or reduced kidney function and are receiving Zavicefta for the first time. Researchers will track any side effects and how well the treatment works over 28 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.